Back to search

Article

Novel PSD95 reporter mice reveal medium spiny neuron subtype-specific synapse loss in PD and L-dopa induced dyskinesia and identify microglia mediated synapse removal as a therapeutic target for dyskinesia

2026-07-09

Abstract excerpt

<h4>Background</h4> L-Dopa remains the primary treatment for Parkinson’s disease (PD), but chronic administration frequently leads to L-Dopa-induced dyskinesia (LID). While D1 and D2 medium spiny neuron (MSN) specific structural changes on the spine level have been observed in the striatum of PD and LID, studying microglia mediated synapse loss has not been done to date. <h4>Methods</h4> Here we generated novel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dd374a82-1c8a-5603-9b7d-1b272e3b3306
DOI
10.64898/2026.07.05.736610
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel PSD95 reporter mice reveal medium spiny neuron subtype-specific synapse loss in PD and L-dopa induced dyskinesia and identify microglia mediated synapse removal as a therapeutic target for dyskinesiaDOI 10.64898/2026.07.05.736610
Select a neighboring publication to make it the new centre.